EIF2AK4 and colorectal carcinoma: In contrast, treatment with other GCN2 inhibitors alone had no effect on cell viability but sensitized a panel of CRC cell lines to asparaginase treatment, which is usually used as an anti-leukemic substance [203,207,208].